eHIV Review

eHIV Review


Newer NNRTI Agents in Clinical Practice

July 11, 2023

Non-nucleoside reverse transcriptase inhibitors (NNRTIs). Rilpivirine, in combination with cabotegravir, provides a long-acting injectable option for both treatment and PrEP. But what risk factors have been associated with virologic failure? Doravirine ap


loaded